Clinical Trial: Atezolizumab and Bevacizumab in Rare Solid Tumors

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase II, Single-Arm Open-Label Study Of The Combination Of Atezolizumab And Bevacizumab In Rare Solid Tumors

Brief Summary: The goal of this clinical research study is to learn if atezolizumab and bevacizumab can help to control rare solid tumors.